ATE454403T1 - Menschliche koagulationsfaktor vii polypeptide - Google Patents

Menschliche koagulationsfaktor vii polypeptide

Info

Publication number
ATE454403T1
ATE454403T1 AT07111713T AT07111713T ATE454403T1 AT E454403 T1 ATE454403 T1 AT E454403T1 AT 07111713 T AT07111713 T AT 07111713T AT 07111713 T AT07111713 T AT 07111713T AT E454403 T1 ATE454403 T1 AT E454403T1
Authority
AT
Austria
Prior art keywords
coagulation factor
human coagulation
factor vii
vii polypeptides
variants
Prior art date
Application number
AT07111713T
Other languages
English (en)
Inventor
Egon Persson
Ole Hvilsted Olsen
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Application granted granted Critical
Publication of ATE454403T1 publication Critical patent/ATE454403T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT07111713T 2002-09-25 2003-09-24 Menschliche koagulationsfaktor vii polypeptide ATE454403T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200201423 2002-09-25

Publications (1)

Publication Number Publication Date
ATE454403T1 true ATE454403T1 (de) 2010-01-15

Family

ID=32039052

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03798087T ATE370968T1 (de) 2002-09-25 2003-09-24 Varianten des menschliche koagulationsfaktors vii
AT07111713T ATE454403T1 (de) 2002-09-25 2003-09-24 Menschliche koagulationsfaktor vii polypeptide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03798087T ATE370968T1 (de) 2002-09-25 2003-09-24 Varianten des menschliche koagulationsfaktors vii

Country Status (7)

Country Link
EP (2) EP1908782B1 (de)
JP (1) JP4597678B2 (de)
AT (2) ATE370968T1 (de)
AU (1) AU2003266214A1 (de)
DE (2) DE60330923D1 (de)
ES (2) ES2293088T3 (de)
WO (1) WO2004029090A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03001984A (es) 2000-09-13 2003-08-29 Novo Nordisk Healthcare Ag Variantes de factor vii de coagulacion humano.
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
US20090176967A1 (en) * 2004-08-02 2009-07-09 Novo Nordisk Healthcare A/G Conjugation of FVII
WO2006018204A1 (en) 2004-08-17 2006-02-23 Zlb Behring Gmbh Modified vitamin k dependent polypeptides
WO2006050247A2 (en) 2004-10-29 2006-05-11 Neose Technologies, Inc. Remodeling and glycopegylation of fibroblast growth factor (fgf)
EP2360171A1 (de) 2004-12-23 2011-08-24 Novo Nordisk Health Care AG Reduktion des Gehaltes an kontaminierenden Proteinen in Zusammensetzungen, die Vitamin K-abhängige Proteine von Interesse umfassen
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
ES2553160T3 (es) 2005-06-17 2015-12-04 Novo Nordisk Health Care Ag Reducción y derivatización selectivas de proteínas Factor VII transformadas por ingeniería que comprenden al menos una cisteína no nativa
WO2007006808A1 (en) 2005-07-13 2007-01-18 Novo Nordisk Health Care Ag Host cell protein knock-out cells for production of therapeutic proteins
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
JP5690047B2 (ja) 2005-09-14 2015-03-25 ノボ ノルディスク ヘルス ケア アーゲー ヒト凝固第ｖｉｉ因子ポリペプチド
EP1929005A1 (de) * 2005-09-21 2008-06-11 Novo Nordisk Health Care AG Menschliche gerinnungsfaktor-vii-polypeptide
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
EP2049144B8 (de) 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylierung von peptiden über o-verbundene glycosylierungssequenzen
WO2008025856A2 (en) 2006-09-01 2008-03-06 Novo Nordisk Health Care Ag Modified glycoproteins
EP2054521A4 (de) 2006-10-03 2012-12-19 Novo Nordisk As Verfahren zur reinigung von polypeptid-konjugate
HRP20130382T1 (hr) 2007-04-03 2013-05-31 Biogenerix Ag Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
CA2683443A1 (en) 2007-04-13 2008-10-23 Catalyst Biosciences, Inc. Modified factor vii polypeptides and uses thereof
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
TWI465247B (zh) 2008-04-11 2014-12-21 Catalyst Biosciences Inc 經修飾的因子ｖｉｉ多肽和其用途
JP2013517782A (ja) 2010-01-28 2013-05-20 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 因子ｖｉｉ融合ポリペプチド
JP2013533871A (ja) 2010-06-30 2013-08-29 ノヴォ ノルディスク アー／エス 組織因子経路インヒビターに特異的に結合することが可能な抗体
WO2012117091A1 (en) 2011-03-02 2012-09-07 Novo Nordisk A/S Coagulation factor-targeting to tlt-1 on activated platelets
US9486507B2 (en) 2011-06-10 2016-11-08 Biogen Ma Inc. Pro-coagulant compounds and methods of use thereof
EP2906236A1 (de) 2012-10-10 2015-08-19 Novo Nordisk Health Care AG Flüssige pharmazeutische zusammensetzung aus faktor-vii-polypeptiden
CN107583031A (zh) * 2016-07-06 2018-01-16 陈栋梁 一种清蛋白肽混合物的制备方法及其抑制癌细胞增殖作用
EP3833381B1 (de) 2019-08-15 2022-08-03 Catalyst Biosciences, Inc. Modifizierte faktor-vii-polypeptide zur subkutanen verabreichung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GB8615942D0 (en) 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
GB8826446D0 (en) 1988-11-11 1988-12-14 Agricultural & Food Res Peptide production
EP0591219B1 (de) 1991-01-11 2001-12-19 American Red Cross Expression von aktivem menschlichem Protein C im Milchdrüsengewebe transgener Tiere
JPH1059866A (ja) * 1996-08-19 1998-03-03 Chemo Sero Therapeut Res Inst 血液凝固第ｖｉｉ因子及び／もしくは活性化血液凝固第ｖｉｉ因子の製造方法
JP4451514B2 (ja) * 1999-08-24 2010-04-14 財団法人化学及血清療法研究所 血液凝固第ｖｉｉ因子改変体
CA2739933A1 (en) * 2000-02-11 2001-08-16 Bayer Healthcare Llc Factor vii or viia-like molecules
US6905683B2 (en) * 2000-05-03 2005-06-14 Novo Nordisk Healthcare A/G Human coagulation factor VII variants
JP4455802B2 (ja) 2000-05-03 2010-04-21 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト ヒト第ｖｉｉ凝固因子変異型
WO2002022776A2 (en) 2000-09-13 2002-03-21 Novo Nordisk A/S Human coagulation factor vii variants
CZ20032454A3 (en) * 2001-03-22 2004-03-17 Novo Nordisk Health Care Ag Coagulation factor vii derivative
CZ2004427A3 (cs) * 2001-09-27 2004-08-18 Novoánordiskáhealthácareáag Polypeptidy lidského koagulačního faktoru VII
US6960657B2 (en) * 2001-11-02 2005-11-01 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides

Also Published As

Publication number Publication date
DE60315847D1 (de) 2007-10-04
AU2003266214A1 (en) 2004-04-19
DE60315847T2 (de) 2008-05-15
EP1546202B1 (de) 2007-08-22
ES2339393T3 (es) 2010-05-19
EP1546202A1 (de) 2005-06-29
EP1908782A1 (de) 2008-04-09
ATE370968T1 (de) 2007-09-15
DE60330923D1 (de) 2010-02-25
EP1908782B1 (de) 2010-01-06
JP4597678B2 (ja) 2010-12-15
WO2004029090A1 (en) 2004-04-08
ES2293088T3 (es) 2008-03-16
JP2006516384A (ja) 2006-07-06

Similar Documents

Publication Publication Date Title
DE60330923D1 (de) Menschliche Koagulationsfaktor VII Polypeptide
TW200407425A (en) Human coagulation factor VII polypeptides
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
NO20031129D0 (no) Varianter av human koagulasjonsfaktor VII
HUP0401124A2 (hu) VII koagulációs faktor származékok
DK1767546T3 (da) Angiogenese-inhiberende kimært protein og dets anvendelse
ATE446313T1 (de) Muteine von tränen-lipocalin
CY1112655T1 (el) Γλυκοζυλιωμενη ιl-7, παρασκευη και χρησεις
NO20041700L (no) Human koagulasjonsfaktor VII-polypeptider
ATE547519T1 (de) Gerinnungsfaktor-vii-polypeptide
ATE407949T1 (de) Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
WO2002022776A3 (en) Human coagulation factor vii variants
WO2007110231A3 (en) MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
NO20073808L (no) BCMA polypeptider og anvendelser derav
WO2005123916A3 (en) Glycosylation-disrupted factor vii variants
WO2005024006A8 (en) Coagulation factor VII polypeptides
EP1613345A4 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
ATE395602T1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
WO2007060213A3 (en) Erythropoietin polypeptides and uses thereof
UA84831C2 (ru) Производные фактора коагуляции vii
DE602004001509D1 (de) Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung
WO2003083071A3 (en) Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
UA81601C2 (ru) Полипептид фактора vii и его применения для лечения случаев кровотечения или усиление нормальной системы кровоостановки

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties